Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Echo Therapeutics Inc (OTCQB:ECTE)

0.08
Delayed Data
As of Apr 26
 0.00 / 0.00%
Today’s Change
0.08
Today|||52-Week Range
2.84
-50.62%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$960.3K

Company Description

Echo Therapeutics, Inc. develops non-invasive, wireless, and continuous glucose monitoring system. It develops needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals. The company was founded on September 14, 2007 and is headquartered in Iselin, NJ.

Contact Information

Echo Therapeutics, Inc.
99 Wood Avenue South
Iselin New Jersey 08830-2734
P:(732) 201-4189
Investor Relations:

Employees

Shareholders

Individual stakeholders10.69%
Mutual fund holders--
Other institutional--

Top Executives

Alan Wayne SchoenbartChief Executive Officer, CFO, Secretary & Director
Christine H. OlimpioDirector-Investor Relations & Communications